Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04396470 Withdrawn - Clinical trials for Prader-Willi Syndrome

tVNS in Children With Prader-Willi Syndrome

Start date: July 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the current project is to test the impact of transcutaneous vagus nerve stimulation (tVNS) on social ability in children with Prader-Willi Syndrome (PWS). Social ability and blood neuropeptides associated with social functioning will be measured before and after engagement in 12 weeks of tVNS therapy.

NCT ID: NCT04395495 Recruiting - Neurofibromatosis 1 Clinical Trials

RASopathy Biorepository

Start date: June 27, 2017
Phase:
Study type: Observational [Patient Registry]

The RASopathies are a group of developmental disorders caused by genetic changes in the genes that compose the Ras/mitogen activated protein kinase (MAPK) pathway. New RASopathies are being diagnosed frequently. This pathway is essential in the regulation of the cell cycle and the determination of cell function. Thus, appropriate function of this pathway is critical to normal development. Each syndrome in this group of disorders has unique phenotypic features, but there are many overlapping features including facial features, heart defects, cutaneous abnormalities, cognitive delays, and a predisposition to malignancies. This research study proposes to collect and store human bio-specimens from patients with suspected or diagnosed RASopathies. Once obtained, blood and/or tissue samples will be processed for: metabolic function studies, biomarkers, genetic studies, and/or the establishment of immortalized cell lines. In addition, data from the medical record (including neuropsychological evaluations) and surveys will be stored to create a longitudinal database for research conducted at CCHMC or at other research institutions.

NCT ID: NCT04395456 Not yet recruiting - Clinical trials for Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)

A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)

SAVE
Start date: September 2021
Phase: Phase 2
Study type: Interventional

The study is a prospective, randomized, placebo-controlled, single-blind phase 2 clinical study of the efficacy and safety of AMY-101, a potent C3 inhibitor, for the management of patients with ARDS caused by SARS-CoV-2 infection. We will assess the efficacy and safety, as well as pharmacokinetics (PK), and pharmacodynamics (PD). The study will assess the impact of AMY-101 in patients with severe COVID19; specifically, it will assess the impact of AMY-101 1) on survival without ARDS and without oxygen requirement at day 21 and 2) on the clinical status of the patients at day 21.

NCT ID: NCT04395404 Recruiting - Clinical trials for Anophthalmos; Acquired

Structural Orbital Changes in Anophthalmic Socket Syndrome

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Understand better the aetiology and physiopathogenesis of anophthalmic socket syndrome.

NCT ID: NCT04395144 Completed - Respiratory Failure Clinical Trials

COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss

COVAYDE
Start date: May 15, 2020
Phase: N/A
Study type: Interventional

Prone positioning is an established intervention in mechanically ventilated acute respiratory distress syndrome (ARDS) patients, with demonstrated reductions in mortality. Preliminary data suggest that awake proning in patients with COVID-19 treated with high-flow nasal oxygenation (HFNO) improves gas exchanges, and might be associated with a reduced need of mechanical ventilation, and reduced mortality. Further investigation in a formal randomized-controlled trial is need.

NCT ID: NCT04394221 Completed - Quality of Life Clinical Trials

OHRQoL and Parental Perception in a Group of Children and Adolescents With Down Syndrome: A Cross

Start date: April 15, 2021
Phase:
Study type: Observational

The aim of the study is to evaluate Oral Health related quality of life of children and adolescents with down syndrome and Parental Perception, knowledge and Attitude on oral health conditions of children and adolescents with down syndrome

NCT ID: NCT04394169 Completed - Covid-19 Clinical Trials

Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.

PAIN-COVID
Start date: May 25, 2020
Phase: N/A
Study type: Interventional

COVID-19 (coronavirus 2019) disease has led to a large number of hospital admissions, many of which require admission to intensive care (ICU). Post-intensive care syndrome (PICS) is defined as deterioration or worsening of previous deterioration in the mental, physical or cognitive status that appears as a consequence of a critical illness and which persists after acute hospital care. Also, there is evidence that patients who survive a critical illness have a high prevalence of moderate to extreme chronic pain. Patients with COVID-19 disease are an especially susceptible population to develop PICS due to acute respiratory distress syndrome (ARDS) survivors have significant long-term deterioration in mental, cognitive, and functional health. This study hypothesis is that a specific care program based on early therapeutic education and psychological intervention improves the quality of life of patients at risk of developing PICS and chronic pain after COVID-19 disease.

NCT ID: NCT04393493 Completed - Clinical trials for Cardiorenal Syndrome

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

Start date: July 1, 2017
Phase: Phase 2
Study type: Interventional

In double-blind clinical trial, determine renal recovery with two different furosemide strategies in patients with type 1 cardiorenal syndrome.

NCT ID: NCT04392934 Completed - Clinical trials for Subacromial Impingement Syndrome

Conservative Physiotherapy and Acromion Morphology

Start date: January 10, 2020
Phase: N/A
Study type: Interventional

In this study, we aimed to evaluate the short-term effects of conservative physiotherapy in the subacromial impingement syndrome (SIS) and its relation to the acromion morphology.

NCT ID: NCT04391634 Completed - Respiratory Failure Clinical Trials

Cerebral and Circulatory Effects of Neonatal Volume Targeted Ventilation

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The aim of the study was to assess the effect of volume targeted vs. pressure-controlled mechanical ventilation (MV) on circulatory parameters and cerebral oxygenation in the extremely preterm infants.